Tuesday, 22 November 2011
  0 Replies
  3.2K Visits
Cool Containers, a new company based in Marietta, OH has developed an innovative, active shipping container called the PharmaPort 360. This first product has been designed for pallet-sized shipments of vaccines and other temperature sensitive products by ground and is FAA approved for air transport. We are currently looking to expand our product line, and we are very confident that the technology we have developed would be useful for vaccine distribution into developing countries. Although our first product is a large container, it is possible to develop smaller and less expensive versions that would be ideal for reliable transport of vaccine into remote areas. We would welcome contact and discussion with those involved in vaccine distribution into developing countries so we can better understand the challanges and needs. Here are a few of the highlighted advantages that our technology offers: *Rechargable system with unique temperature storage technology. *The system plugs in to any standard electric source (100V, 115V, 230V, or could be a car battery) to charge the system. *No need for dry ice, ice packs, refrigeration consumables *Active control of temperature during transport *High accuracy and uniformity of temperature (5C +/- 1.0 C) *Long hold times: maintains 5C for 3-4 days without external power (could be longer if needed) *GSM Mobile monitoring and GPS locating system: a manager can see online the location, temp status of the container, and can receive an alert many hours before the temperature would go outside of the 2-8C range. *Can be used as both a cold chain transport container, and when plugged-in can be used as a vaccine refrigerator. Please visit our website: http://www.coolcontainersllc.com for additional information on our company and products, and post a reply or contact me (Mike Rosenblum) directly at [email protected] with any questions or input. As mentioned, we are very interested in collaborating with any groups interested in our technology so we may fine tune a solution for vaccine distribution.
There are no replies made for this post yet.